Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11504354 Chlorinated tetralin compounds and pharmaceutical compositions

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

SpringWorks Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 22, 2022

Patent Application Number

17860682

Date Filed

July 8, 2022

Patent Citations

US Patent 10710966 Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

US Patent 10590087 Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

Patent Citations Received

US Patent 12110277 Synthesis of nirogacestat

0

Patent Primary Examiner

Leslie A. Royds Draper

The present disclosures are directed to chlorinated tetralin compounds and pharmaceutical compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11504354 Chlorinated tetralin compounds and pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool